William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 14,120 shares at $74.31 ($1.0M) on 2025-05-06, disclosed to the SEC on 2025-05-08.
Scheduled sale ($1.0M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.31 | 7,060 | $525K | 50.0% |
| 2 | $74.31 | 7,060 | $525K | 50.0% |
| Total | $74.31 avg | 14,120 | $1.0M | 100% |
| Filing → |
| CORT | SELL | 2026-06-04 | $1.4M | — | Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |